Effect of zexbrevins A and B. Two new sesquiterpene lactones, on the immune response of mice.

Two newly described sesquiterpene lactones, Zexbrevin A and Zexbrevin B, were administered to mice at microgram doses before a single immunizing dose of sheep red blood cells (SRBC), bovine serum albumine (BSA), or Egg albumin (Ea). It was found out that drug treated and immunized animals displayed high numbers of specific spleen rosette forming cells (RFC), as well as elevated titers of circulating antibodies, as compared with mice stimulated solely with antigens. 500 mug of Zexbrevin A and Zexbrevin B was about the best dose for rosette increase; 700 mug or lesser amounts of both drugs induced a decline in the rosette numbers. It was evident that Zexbrevins had to be administered 48 hours before antigen stimulation; no potentiation was obtained if the drugs were given 3 to 11 days before the antigen. No effect was obtained, as well, when mice were treated with drug and antigen on the same day. In the presence of Zexbrevins the radioactive thymidine uptake of cultured normal mouse spleen cells will not increase above controls, indicating that mitogenic effects appear not to be involved in the potentiation. It is concluded that the sesquiterpene lactones exert in mice a potent stimulation of the in vivo response.